The Enterprise Value as of December 2025 (TTM) for Shanghai Junshi Biosciences Co., Ltd. (1877.HK) is 35.89B

According to Shanghai Junshi Biosciences Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 35.89B. This represents a change of 6.55% compared to the average of 33.68B of the last 4 quarters.

Shanghai Junshi Biosciences Co., Ltd. (1877.HK) Historical Enterprise Value (quarterly & annually)

How has 1877.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Shanghai Junshi Biosciences Co., Ltd. over the last ten years is 71.36B. The current 35.89B Enterprise Value has changed 4.93% with respect to the historical average. Over the past ten years (40 quarters), 1877.HK's Enterprise Value was at its highest in in the December 2016 quarter at 133.15B. The Enterprise Value was at its lowest in in the September 2017 quarter at 0.

Shanghai Junshi Biosciences Co., Ltd. (1877.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Shanghai Junshi Biosciences Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Shanghai Junshi Biosciences Co., Ltd. (1877.HK) Average Enterprise Value

How has 1877.HK Enterprise Value performed in the past?

The current Enterprise Value of Shanghai Junshi Biosciences Co., Ltd. (1877.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Shanghai Junshi Biosciences Co., Ltd. (1877.HK) Enterprise Value vs. Peers

How is 1877.HK’s Enterprise Value compared to its peers?

Shanghai Junshi Biosciences Co., Ltd.’s Enterprise Value is greater than Shanghai Henlius Biotech, Inc. (33.54B), greater than Genscript Biotech Corporation (3.95B), less than RemeGen Co., Ltd. (45.85B), greater than Simcere Pharmaceutical Group Limited (27.73B), greater than Duality Biotherapeutics, Inc. (23.89B), greater than Ascentage Pharma Group International (19.02B), greater than Asymchem Laboratories (Tianjin) Co., Ltd. (25.23B), greater than Zai Lab Limited (1.43B), greater than Everest Medicines Limited (15.08B), less than Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (48.90B),

Build a custom stock screener for Shanghai Junshi Biosciences Co., Ltd. (1877.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shanghai Junshi Biosciences Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shanghai Junshi Biosciences Co., Ltd. (1877.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shanghai Junshi Biosciences Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.